HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Collagen-polyvinylpyrrolidone: a new therapeutic option for treatment of sequelae after radical mastectomy in women with breast cancer. Preliminary study].

AbstractBACKGROUND:
Approximately 30% of women who undergo mastectomy without reconstructive treatment due to breast cancer present sequelae. These include paresthesias, keloid healing, hypoesthesia, lymphedema and limitation of the function of the ipsilateral upper extremity. We undertook this study to present the results using collagen-polyvinylpyrrolidone (Clg- Pvp) as treatment for posmastectomy sequelae in women with breast cancer.
METHODS:
We conducted a unicentric, longitudinal and prospective clinical trial between August 1, 2007 and July 31, 2008. Included variables were age, lymphedema, limitation of the function of the ipsilateral upper extremity, collapse of the wound, keloid healing, paresthesias, and appearance of the surgical area. The appearance of the surgical area (aesthetic aspect) was evaluated before and 6 months after treatment was initiated. Clg-Pvp was administered weekly for a 6-month period.
RESULTS:
Seven women were included with a median age of 49 years (range: 40-72 years). One patient (14.28%) presented lymphedema, two patients (28.57%) presented collapse of the wound, two patients (28.57%) had keloid healing, three patients (42.85%) experienced paresthesias, five patients (71.4%) reported pain, and five patients (71.4%) reported limitation of the function of the ipsilateral upper extremity. At the completion of the treatment, aesthetic improvement was statistically significant (p = 0.0020, Mann-Whitney U test).
CONCLUSIONS:
Clinical and aesthetic results are good after application of Clg-Pvp for treating sequelae in women with breast cancer who underwent mastectomy without reconstructive surgery.
AuthorsRafael Ruiz-Eng, Alvaro Montiel-Jarquín, Raúl de la Rosa-Pérez, Aurelio López-Colombo, Eduardo Gómez-Conde, Leticia Zamudio-Huerta
JournalCirugia y cirujanos (Cir Cir) 2010 Jul-Aug Vol. 78 Issue 4 Pg. 310-4 ISSN: 2444-054X [Electronic] Mexico
Vernacular TitleColágeno-polivinilpirrolidona, nueva opción para tratar secuelas de la mastectomía radical en mujeres con cáncer mamario. Informe preliminar.
PMID21167096 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Dermatologic Agents
  • collagen-PVP
  • Collagen
  • Povidone
Topics
  • Adult
  • Aged
  • Arm
  • Breast Neoplasms (surgery)
  • Cicatrix (etiology, prevention & control)
  • Collagen (administration & dosage, pharmacology, therapeutic use)
  • Dermatologic Agents (administration & dosage, therapeutic use)
  • Esthetics
  • Female
  • Humans
  • Injections, Subcutaneous
  • Keloid (etiology, prevention & control)
  • Lymph Node Excision (adverse effects)
  • Lymphedema (etiology, prevention & control)
  • Mastectomy, Radical (adverse effects)
  • Middle Aged
  • Paresthesia (etiology, prevention & control)
  • Povidone (administration & dosage, pharmacology, therapeutic use)
  • Prospective Studies
  • Range of Motion, Articular
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: